List of Tables
Table 1. Global Oncolytic Bacterial Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Intratumoral Injection
Table 3. Key Players of Intravenous Injection
Table 4. Global Oncolytic Bacterial Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Oncolytic Bacterial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oncolytic Bacterial Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Oncolytic Bacterial Drugs Market Share by Region (2020-2025)
Table 8. Global Oncolytic Bacterial Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Oncolytic Bacterial Drugs Market Share by Region (2026-2031)
Table 10. Oncolytic Bacterial Drugs Market Trends
Table 11. Oncolytic Bacterial Drugs Market Drivers
Table 12. Oncolytic Bacterial Drugs Market Challenges
Table 13. Oncolytic Bacterial Drugs Market Restraints
Table 14. Global Oncolytic Bacterial Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Oncolytic Bacterial Drugs Market Share by Players (2020-2025)
Table 16. Global Top Oncolytic Bacterial Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Bacterial Drugs as of 2024)
Table 17. Ranking of Global Top Oncolytic Bacterial Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Oncolytic Bacterial Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Oncolytic Bacterial Drugs, Headquarters and Area Served
Table 20. Global Key Players of Oncolytic Bacterial Drugs, Product and Application
Table 21. Global Key Players of Oncolytic Bacterial Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oncolytic Bacterial Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Oncolytic Bacterial Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global Oncolytic Bacterial Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Oncolytic Bacterial Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global Oncolytic Bacterial Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Oncolytic Bacterial Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global Oncolytic Bacterial Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Oncolytic Bacterial Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America Oncolytic Bacterial Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Oncolytic Bacterial Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Oncolytic Bacterial Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Oncolytic Bacterial Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Oncolytic Bacterial Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Oncolytic Bacterial Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Oncolytic Bacterial Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Oncolytic Bacterial Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Oncolytic Bacterial Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oncolytic Bacterial Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Oncolytic Bacterial Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Oncolytic Bacterial Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Oncolytic Bacterial Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Oncolytic Bacterial Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Oncolytic Bacterial Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Salvector Company Details
Table 47. Salvector Business Overview
Table 48. Salvector Oncolytic Bacterial Drugs Product
Table 49. Salvector Revenue in Oncolytic Bacterial Drugs Business (2020-2025) & (US$ Million)
Table 50. Salvector Recent Development
Table 51. Guangzhou Sinogen Pharmaceutical Company Details
Table 52. Guangzhou Sinogen Pharmaceutical Business Overview
Table 53. Guangzhou Sinogen Pharmaceutical Oncolytic Bacterial Drugs Product
Table 54. Guangzhou Sinogen Pharmaceutical Revenue in Oncolytic Bacterial Drugs Business (2020-2025) & (US$ Million)
Table 55. Guangzhou Sinogen Pharmaceutical Recent Development
Table 56. HKND YB1 PHARMACEUTUCAL Company Details
Table 57. HKND YB1 PHARMACEUTUCAL Business Overview
Table 58. HKND YB1 PHARMACEUTUCAL Oncolytic Bacterial Drugs Product
Table 59. HKND YB1 PHARMACEUTUCAL Revenue in Oncolytic Bacterial Drugs Business (2020-2025) & (US$ Million)
Table 60. HKND YB1 PHARMACEUTUCAL Recent Development
Table 61. Shandong Xinchuang Biotechnology Company Details
Table 62. Shandong Xinchuang Biotechnology Business Overview
Table 63. Shandong Xinchuang Biotechnology Oncolytic Bacterial Drugs Product
Table 64. Shandong Xinchuang Biotechnology Revenue in Oncolytic Bacterial Drugs Business (2020-2025) & (US$ Million)
Table 65. Shandong Xinchuang Biotechnology Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
Table 69. Authors List of This Report
List of Figures
Figure 1. Oncolytic Bacterial Drugs Picture
Figure 2. Global Oncolytic Bacterial Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncolytic Bacterial Drugs Market Share by Type: 2024 VS 2031
Figure 4. Intratumoral Injection Features
Figure 5. Intravenous Injection Features
Figure 6. Global Oncolytic Bacterial Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Oncolytic Bacterial Drugs Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Oncolytic Bacterial Drugs Report Years Considered
Figure 12. Global Oncolytic Bacterial Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Oncolytic Bacterial Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oncolytic Bacterial Drugs Market Share by Region: 2024 VS 2031
Figure 15. Global Oncolytic Bacterial Drugs Market Share by Players in 2024
Figure 16. Global Oncolytic Bacterial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Oncolytic Bacterial Drugs Revenue in 2024
Figure 18. North America Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Oncolytic Bacterial Drugs Market Share by Country (2020-2031)
Figure 20. United States Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oncolytic Bacterial Drugs Market Share by Country (2020-2031)
Figure 24. Germany Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oncolytic Bacterial Drugs Market Share by Region (2020-2031)
Figure 32. China Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oncolytic Bacterial Drugs Market Share by Country (2020-2031)
Figure 40. Mexico Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oncolytic Bacterial Drugs Market Share by Country (2020-2031)
Figure 44. Turkey Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Oncolytic Bacterial Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Salvector Revenue Growth Rate in Oncolytic Bacterial Drugs Business (2020-2025)
Figure 48. Guangzhou Sinogen Pharmaceutical Revenue Growth Rate in Oncolytic Bacterial Drugs Business (2020-2025)
Figure 49. HKND YB1 PHARMACEUTUCAL Revenue Growth Rate in Oncolytic Bacterial Drugs Business (2020-2025)
Figure 50. Shandong Xinchuang Biotechnology Revenue Growth Rate in Oncolytic Bacterial Drugs Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed